Nektar Therapeutics

NKTRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.282 B

$66.84 -0.39%

Close of 21 Sept 2026

Revenue

$55.2M

#2697 by revenue

Earnings

-$164.0M

Loss-making

Shares outstanding

34,142,994

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#92Viridian TherapeuticsVRDN$2.44B
#93SELLAS Life Sciences GroupSLS$2.30B
#94Nektar TherapeuticsNKTR$2.28B
#95SchrodingerSDGR$2.26B
#96Braveheart BioBRVE$2.25B

What if Nektar Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.3T

$886,684.22

Per share 13,266× higher

Bitcoin $1.72T

$50,370.62

Per share 754× higher

Nvidia $5.48T

$160,497.29

Per share 2,401× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Nektar Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.